Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, 10003 Cáceres, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), 28029 Madrid, Spain.
Cells. 2024 Mar 30;13(7):609. doi: 10.3390/cells13070609.
Cardiolipin (CL) is a mitochondria-exclusive phospholipid synthesized in the inner mitochondrial membrane. CL plays a key role in mitochondrial membranes, impacting a plethora of functions this organelle performs. Consequently, it is conceivable that abnormalities in the CL content, composition, and level of oxidation may negatively impact mitochondrial function and dynamics, with important implications in a variety of diseases. This review concentrates on papers published in recent years, combined with basic and underexplored research in CL. We capture new findings on its biological functions in the mitochondria, as well as its association with neurodegenerative diseases such as Alzheimer's disease or Parkinson's disease. Lastly, we explore the potential applications of CL as a biomarker and pharmacological target to mitigate mitochondrial dysfunction.
心磷脂(CL)是一种仅存在于线粒体中的磷脂,在内膜中合成。CL 在线粒体膜中起着关键作用,影响着线粒体执行的多种功能。因此,可以想象,CL 的含量、组成和氧化水平的异常可能会对线粒体功能和动力学产生负面影响,这对各种疾病都有着重要的影响。本综述集中于近年来发表的论文,并结合了 CL 领域的基础和未充分研究的内容。我们总结了 CL 在生物功能方面的新发现,以及它与神经退行性疾病(如阿尔茨海默病或帕金森病)的关联。最后,我们探讨了将 CL 作为生物标志物和药理学靶点来减轻线粒体功能障碍的潜在应用。